Right-Sided clinical findings are worse prognostic factor in Multiple Sclerosis patients?

References

1. ↵
   1. Al-Abdullah MS,
   2. Siddiqui AF

   (2018) Demographic and disease characteristics of multiple sclerosis in the Southwest Region of Saudi Arabia. Neurosciences (Riyadh) 23, 320–325.
2. ↵
   1. Fragomeni MO,
   2. Bichuetti DB,
   3. Oliveira EML

   (2018) Pediatric-onset multiple sclerosis in Brazilian patients: Clinical features, treatment response and comparison to pediatric neuromyelitis optica spectrum disorders. Mult Scler Relat Disord 25, 138–142.
3. ↵
   1. Frau J,
   2. Villar LM,
   3. Sardu C,
   4. Secci MA,
   5. Schirru L,
   6. Ferraro D,
   7. et al.

   (2018) Intrathecal oligoclonalbands synthesis in multiple sclerosis: is it always a prognostic factor? J Neurol 265, 424–430.
4. ↵
   1. Novakova L,
   2. Axelsson M,
   3. Malmeström C,
   4. Imberg H,
   5. Elias O,
   6. Zetterberg H,
   7. et al.

   (2018) Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers. PLoSOne 13, e0194828.
5. ↵
   1. Neveu PJ,
   2. Betancur C,
   3. Barnéoud P,
   4. Vitiello S,
   5. Le Moal M

   (1991) Functional brain asymmetry and lymphocyte proliferation in female mice: effects of right and left cortical ablation. Brain Res 31, 125–128.
6. ↵
   1. Gontova IA,
   2. Abramov VV,
   3. Kozlov VA

   (2003) Asymmetry of delayed type hypersensitivity reaction in mice. Bull Exp Biol Med 135, 67–69.
7. ↵
   1. Gontova IA,
   2. Abramov VV,
   3. Kozlov VA

   (2004) The role of asymmetry of nervous and immune systems in the formation of cellular immunity of (CBaxC57Bl/6) F1 mice. Neuroimmunomodulation 11, 385–391.
8. ↵
   1. Dane S,
   2. Borekci B,
   3. Kadanali S

   (2008) Right-sided lateralisation of ovarian cancer and right bias asymmetry for involved pelvic lymphnodes by ovarian cancer cells. Laterality 13, 393–402.
9. ↵
   1. Yoruk O,
   2. Karasen M,
   3. Timur H,
   4. Erdem T,
   5. Dane S,
   6. Tan U

   (2009) Lateralizations of head-neck cancers are not associated with peripheral asymmetry of cell-mediated immunity. Int J Neurosci 119, 815–820.
10. ↵
    1. Kramer MA,
    2. Albrecht S,
    3. Miller RA

    (1985) Handedness and the laterality of breast cancer in women. Nurs Res 34, 333–337.
11. ↵
    1. Dane S,
    2. Erdem T,
    3. Gümüştekin K

    (2001) Cell-mediated immune hypersensitivity is stronger in the leftside of the body than the right in healthy young subjects. Percept Mot Skills 93, 329–332.
12. ↵
    1. Fu QL,
    2. Shen YQ,
    3. Gao MX,
    4. Dong J,
    5. Neveu PJ,
    6. Li KS

    (2003) Brain interleukin asymmetries and paw preference in mice. Neuroscience 116, 639–647.
13. ↵
    1. Nedeljkovic U,
    2. Dackovic J,
    3. Tepavcevic DK,
    4. Basuroski ID,
    5. Mesaros S,
    6. Pekmezovic T,
    7. et al.

    (2016) Multidisciplinary rehabilitation and steroids in the management of multiple sclerosis relapses: a randomized controlledtrial. Arch Med Sci 12, 380–389.
14. ↵
    1. Kurtzke JF

    (1983) Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 33, 1444–1452.
15. ↵
    1. Roxburgh RH,
    2. Seaman SR,
    3. Masterman T,
    4. Hensiek AE,
    5. Sawcer SJ,
    6. Vukusic S

    (2005) Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 64, 1144–1151.
16. ↵
    1. Cendrowski WS

    (1986) Progression index and disability status in multiple sclerosis: a resurvey of 207 patients in central Poland. Schweiz Arch Neurol Psychiatr 137, 5–13.
17. ↵
    1. Gerendai I,
    2. Halász B

    (1997) Neuroendocrine asymmetry. Front Neuroendocrinol 18, 354–381.
18. ↵
    1. Shen YQ,
    2. Hébert G,
    3. Moze E,
    4. Li KS,
    5. Neveu PJ

    (2005) Asymmetrical distribution of brain interleukin-6 depends on lateralization in mice. Neuroimmunomodulation 12, 189–194.
19. ↵
    1. Algra A,
    2. Gates PC,
    3. Fox AJ,
    4. Hachinski V,
    5. Barnett HJ

    (2003) North American Symptomatic Carotid Endarterectomy Trial Group. Side of brain infarction and long-term risk of sudden death in patients with symptomatic carotid disease. Stroke 34, 2871–2875.
20. ↵
    1. Denarié N,
    2. Gariepy J,
    3. Chironi G,
    4. Massonneau M,
    5. Laskri F,
    6. Salomon J,
    7. et al.

    (2000) Distribution of ultrasonographically-assessed dimensions of common carotid arteries in healthy adults of both sexes. Atherosclerosis 148, 297–302.
21. ↵
    1. Rodríguez Hernández SA,
    2. Kroon AA,
    3. vanBoxtel MP,
    4. Mess WH,
    5. Lodder J,
    6. Jolles J,
    7. et al.

    (2003) Is there a side predilection for cerebrovascular disease? Hypertension 42, 56–60.
22. ↵
    1. Turnbull AV,
    2. Rivier CL

    (1999) Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol Rev 79, 1–71.
23. ↵
    1. Renoux G,
    2. Bizière K,
    3. Renoux M,
    4. Guillaumin JM,
    5. Degenne DA

    (1983) Balanced brain asymmetry modulates T cell-mediated events. J Neuroimmunol 5, 227–238.
24. ↵
    1. Bardos P,
    2. Degenne D,
    3. Lebranchu Y,
    4. Bizière K,
    5. Renoux G

    (1981) Neocortical lateralization of NK activity in mice. Scand J Immunol 13, 609–611.
25. ↵
    1. Arrambide G,
    2. Rovira A,
    3. Sastre-Garriga J,
    4. Tur C,
    5. Castilló J,
    6. Río J

    (2018) Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor. Mult Scler 24, 301–312.
26. ↵
    1. Tintore M,
    2. Otero-Romero S,
    3. Río J,
    4. Arrambide G,
    5. Pujal B,
    6. Tur C

    (2016) Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis. Neurology 87, 1368–1374.
27. ↵
    1. Jetté N,
    2. Amoozegar F,
    3. Patten SB

    (2017) Depression in epilepsy, migraine, and multiple sclerosis: Epidemiologyand how to screen for it. Neurol Clin Pract 7, 118–127.
28. ↵
    1. Pauwels I,
    2. Cosemans L,
    3. Boonen S,
    4. Dubois B,
    5. Goris A

    (2013) Rare MEFV variants are not associated with risk to develop multiple sclerosis and severity of disease. Mult Scler 19, 1132–1136.